Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 63401-63450 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT06348693
Development of Therapeutic Approaches Modulating Molecular Targets Implicated on Cancer Stem Cell-related Aggressiveness
N/ARecruiting
400 participants
Started: Apr 19, 2017 · Completed: Nov 21, 2025
3 conditions1 sponsor1 location
NCT03286634
ASIA Down Syndrome Acute Lymphoblastic Leukemia 2016
PHASE2Recruiting
60 participants
Started: Apr 18, 2017 · Completed: Mar 31, 2033
3 conditions1 sponsor10 locations
NCT03138161
SAINT:Trabectedin, Ipilimumab and Nivolumab for Previously Treated Advanced Soft Tissue Sarcoma
PHASE1/PHASE2Recruiting
250 participants
Started: Apr 13, 2017 · Completed: Jul 31, 2031
2 conditions1 sponsor1 location
NCT05299814
Impact of Parental Emotion Regulation on the Treatment of ADHD
NARecruiting
65 participants
Started: Apr 13, 2017 · Completed: Oct 31, 2025
1 condition1 sponsor1 location
NCT02984761
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
NARecruiting
670 participants
Started: Apr 13, 2017 · Completed: Sep 30, 2027
1 condition1 sponsor17 locations
NCT02644265
CONNECT-ME: Consciousness in Neurocritical Care Cohort Study Using fMRI and EEG
N/ARecruiting
100 participants
Started: Apr 12, 2017 · Completed: Dec 31, 2025
2 conditions2 sponsors1 location
NCT03207854
Collection of Immunology Specimens From Patients With Cancer or Blood Disorders, and Healthy Volunteers
N/ARecruiting
500 participants
Started: Apr 12, 2017 · Completed: Apr 12, 2027
5 conditions2 sponsors1 location
NCT03017755
Scoliosis Survey to Development Treatment Decision Tool
N/ARecruiting
5,000 participants
Started: Apr 11, 2017 · Completed: Dec 15, 2025
1 condition1 sponsor1 location
NCT02936024
One Stage vs. Two Stage Gubernaculum Sparing Laparoscopic Orchidopexy (GSLO)
NARecruiting
80 participants
Started: Apr 11, 2017 · Completed: Sep 30, 2025
1 condition2 sponsors1 location
NCT03089554
Evaluating Genomic Testing in Human Cancer & Outcomes of Targeted Therapies
PHASE2Recruiting
93 participants
Started: Apr 11, 2017 · Completed: Apr 30, 2026
1 condition1 sponsor1 location
NCT03080129
Microbiome and Sarcopenia in Patients With Liver Cirrhosis
NARecruiting
120 participants
Started: Apr 11, 2017 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT02975310
In-clinic Endoscopic Polypectomy for Chronic Sinusitis With Nasal Polyps
NARecruiting
140 participants
Started: Apr 11, 2017 · Completed: Dec 31, 2025
2 conditions3 sponsors4 locations
NCT03120481
Controls for Respiratory Diseases
N/ARecruiting
1,572 participants
Started: Apr 10, 2017 · Completed: Feb 28, 2037
6 conditions1 sponsor1 location
NCT03156478
STOP DIABETES - Knowledge-based Solutions
NARecruiting
10,000 participants
Started: Apr 10, 2017 · Completed: Dec 31, 2037
5 conditions15 sponsors1 location
NCT02926859
Enhancing Recovery in Early Schizophrenia
PHASE2Recruiting
180 participants
Started: Apr 8, 2017 · Completed: Jun 30, 2026
1 condition1 sponsor6 locations
NCT06365424
Fenofibrate in Patients With Primary Biliary Cholangitis (PBC)
PHASE2/PHASE3Recruiting
117 participants
Started: Apr 8, 2017 · Completed: Apr 30, 2027
1 condition1 sponsor1 location
NCT03050268
Familial Investigations of Childhood Cancer Predisposition
N/ARecruiting
3,000 participants
Started: Apr 6, 2017 · Completed: Mar 31, 2037
46 conditions1 sponsor1 location
NCT03221322
How do Super Lean Subjects Keep Resistant to Body Weight Gain?
N/ARecruiting
300 participants
Started: Apr 6, 2017 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT02830724
Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers
PHASE1/PHASE2Recruiting
124 participants
Started: Apr 6, 2017 · Completed: Jan 1, 2028
5 conditions1 sponsor1 location
NCT03007030
Brentuximab Vedotin in Treating Patients With CD30+ Malignant Mesothelioma That Cannot Be Removed by Surgery
PHASE2Recruiting
55 participants
Started: Apr 5, 2017 · Completed: May 1, 2026
2 conditions2 sponsors1 location
NCT03017820
A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma
PHASE1Recruiting
127 participants
Started: Apr 4, 2017 · Completed: Apr 1, 2032
19 conditions2 sponsors2 locations
NCT05628701
Colectomy Reconstruction for Ulcerative Colitis, Ileorectal Anastomosis vs Ileal Pouch-Anal Anastomosis in Ulcerative Colitis.
NARecruiting
100 participants
Started: Apr 4, 2017 · Completed: Dec 31, 2029
3 conditions4 sponsors4 locations
NCT05619588
Exactech Vantage Total Ankle System Post Market Clinical Follow-Up - US Only
N/ARecruiting
370 participants
Started: Apr 4, 2017 · Completed: Sep 30, 2031
3 conditions1 sponsor2 locations
NCT04090268
Precision Exercise in Children With Malignant Hemopathies
NARecruiting
380 participants
Started: Apr 3, 2017 · Completed: Apr 3, 2026
8 conditions2 sponsors1 location
NCT03003117
The prEgnanCy and eArly Childhood nutrItion triaL (ECAIL)
NARecruiting
800 participants
Started: Apr 3, 2017 · Completed: Dec 31, 2027
5 conditions6 sponsors2 locations
NCT05382585
Newer Therapeutic Targets in Head and Neck Cancers
N/ARecruiting
200 participants
Started: Apr 1, 2017 · Completed: Dec 31, 2027
2 conditions1 sponsor1 location
NCT03775577
Exercise Intolerance in Heart Failure
N/ARecruiting
130 participants
Started: Apr 1, 2017 · Completed: Aug 31, 2027
1 condition2 sponsors1 location
NCT03593148
The Effect of Lifestyle Treatment in Patients With Morbid Obesity
NARecruiting
600 participants
Started: Apr 1, 2017 · Completed: Dec 23, 2025
4 conditions2 sponsors1 location
NCT03051282
Genetic Determinants of ACEI Prodrug Activation
PHASE4Recruiting
30 participants
Started: Apr 1, 2017 · Completed: Jan 1, 2026
1 condition1 sponsor1 location
NCT03305861
Green LEP vs ThuLEP in Management of Marked Enlarged Prostate
NARecruiting
110 participants
Started: Apr 1, 2017 · Completed: Nov 1, 2024
1 condition1 sponsor1 location
NCT03343873
The Effects of Different Anesthetics on Functional Connectivity
NARecruiting
240 participants
Started: Apr 1, 2017 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT03124212
Cascade Genetic Testing for Hereditary Breast/Ovarian Cancer and Lynch Syndrome in Switzerland
N/ARecruiting
700 participants
Started: Apr 1, 2017 · Completed: Sep 30, 2027
2 conditions4 sponsors9 locations
NCT03097939
Phase 2 Trial of Ipilimumab and Nivolumab in Nasopharyngeal Carcinoma
PHASE2Recruiting
113 participants
Started: Mar 31, 2017 · Completed: Dec 31, 2024
1 condition3 sponsors1 location
NCT03192267
Early Rheumatoid Arthritis Lung Disease Study
N/ARecruiting
100 participants
Started: Mar 31, 2017 · Completed: Mar 31, 2029
1 condition1 sponsor1 location
NCT03242382
Trial of Palbociclib in Second Line of Advanced Sarcomas With CDK4 Overexpression.
PHASE2Recruiting
40 participants
Started: Mar 31, 2017 · Completed: Sep 30, 2024
3 conditions1 sponsor19 locations
NCT03107533
Scoliosis Shared Decision Making
N/ARecruiting
25 participants
Started: Mar 30, 2017 · Completed: Mar 31, 2026
1 condition1 sponsor1 location
NCT03094429
An Adaptive Phase II/III, Two-Part, Double-Blind, Randomized, Placebo-controlled, Dose-Finding, Multi-center Study of the Safety and Efficacy of NaBen®, as an Add-on Therapy With Clozapine, for Residual Symptoms of Refractory Schizophrenia in Adults
PHASE2/PHASE3Recruiting
287 participants
Started: Mar 29, 2017 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT03026140
Neoadjuvant Immune Checkpoint Inhibition and Novel IO Combinations in Early-stage Colon Cancer
PHASE2Recruiting
353 participants
Started: Mar 29, 2017 · Completed: Mar 1, 2032
1 condition2 sponsors6 locations
NCT03238378
Salvage Brachytherapy and Hyperthermia for Recurrent H&N-tumours
NARecruiting
96 participants
Started: Mar 29, 2017 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT03129854
Androgen Deprivation Therapy (ADT) Versus ADT Plus Prostate Cryotherapy for Metastatic Prostate Cancer (mPCa)
NARecruiting
250 participants
Started: Mar 29, 2017 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT05397262
Organ-preservative Therapy of Bladder Cancer With Radiotherapy or Radiochemotherapy Combined With Hyperthermia
NARecruiting
1,000 participants
Started: Mar 29, 2017 · Completed: Dec 31, 2099
1 condition1 sponsor1 location
NCT02784119
APCext : Effect of Temporary Porto-caval Shunt During Liver Transplantation on Function of Liver Graft From Extended Criteria Donor
NARecruiting
214 participants
Started: Mar 28, 2017 · Completed: Jul 31, 2025
1 condition1 sponsor6 locations
NCT02923011
Comparative Effectiveness of MRgFUS Versus CTgRFA for Osteoid Osteomas
PHASE3Recruiting
56 participants
Started: Mar 28, 2017 · Completed: Jun 30, 2025
1 condition2 sponsors3 locations
NCT03231150
Plantar Fasciitis Randomized Clinical Control Trial
NARecruiting
62 participants
Started: Mar 28, 2017 · Completed: Oct 31, 2026
1 condition1 sponsor1 location
NCT02932007
Chloroquine for Patients With Symptomatic Persistent Atrial Fibrillation: A Prospective Pilot Study
PHASE2Recruiting
40 participants
Started: Mar 28, 2017 · Completed: Sep 30, 2020
1 condition1 sponsor1 location
NCT03108001
Glowing and Expecting Follow Up
N/ARecruiting
514 participants
Started: Mar 27, 2017 · Completed: Mar 1, 2031
1 condition1 sponsor1 location
NCT02915120
Ultrasound-Guided Pulsed Radiofrequency In The Treatment Of Patients With Osteoarthritis Knee (USPRFGENOAK)
NARecruiting
142 participants
Started: Mar 27, 2017 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT03037684
Depolarising Electrical Skin Stimulation in Neuropathic and Postoperative Pain
N/ARecruiting
75 participants
Started: Mar 27, 2017 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT03048201
Physica System Total Knee Replacement Registry Study
NARecruiting
800 participants
Started: Mar 24, 2017 · Completed: Mar 31, 2030
6 conditions1 sponsor5 locations
NCT05250375
Natural History Study of Mitochondrial Myopathy
N/ARecruiting
1,300 participants
Started: Mar 24, 2017 · Completed: Mar 24, 2030
1 condition5 sponsors1 location